000			01384 a2200349 4500
005			20250516151546.0
264		0	_c20131216
008			201312s 0 0 eng d
022			_a1464-3391
024	7		_a10.1016/j.bmc.2013.04.033 _2doi
040			_aNLM _beng _cNLM
100	1		_aVandekerckhove, Stéphanie
245	0	0	_aExploration of aziridine- and β-lactam-based hybrids as both bioactive substances and synthetic intermediates in medicinal chemistry. _h[electronic resource]
260			_bBioorganic & medicinal chemistry _cJul 2013
300			_a3643-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntimalarials _xchemical synthesis
650	0	4	_aAntiviral Agents _xchemical synthesis
650	0	4	_aAziridines _xchemical synthesis
650	0	4	_aChemistry, Pharmaceutical
650	0	4	_aDrug Discovery
650	0	4	_aHumans
650	0	4	_aMalaria, Falciparum _xdrug therapy
650	0	4	_aPlasmodium falciparum _xdrug effects
650	0	4	_aPurines _xchemical synthesis
650	0	4	_aQuinolines _xchemical synthesis
650	0	4	_abeta-Lactams _xchemical synthesis
700	1		_aD'hooghe, Matthias
773	0		_tBioorganic & medicinal chemistry _gvol. 21 _gno. 13 _gp. 3643-7
856	4	0	_uhttps://doi.org/10.1016/j.bmc.2013.04.033 _zAvailable from publisher's website
999			_c22761096 _d22761096